Modulation of ribonuclease P activity by calcipotriol

European Journal of Biochemistry

Volumn 267, Issue 4, 2000, Pages 1173-1177

  Papadimou, Evangelia ^a   Monastirli, Alexandra ^b   Stathopoulos, Constantinos ^a   Tsambaos, Dionysios ^b   Drainas, Denis ^a  

^a Departments of Biochemistry   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Ribozymes; RNase P; Vitamin D

Indexed keywords

CALCIPOTRIOL; COLECALCIFEROL; RIBONUCLEASE P; TRANSFER RNA;

ARTICLE; DICTYOSTELIUM DISCOIDEUM; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PURIFICATION; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; SIGNAL TRANSDUCTION;

ANIMALS; CALCITRIOL; CHOLECALCIFEROL; CHOLESTEROL; DEHYDROCHOLESTEROLS; DICTYOSTELIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDORIBONUCLEASES; ENZYME ACTIVATION; KINETICS; RIBONUCLEASE P; RIBONUCLEASE, PANCREATIC; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, CATALYTIC; RNA, TRANSFER; STRUCTURE-ACTIVITY RELATIONSHIP;

DICTYOSTELIUM DISCOIDEUM; MYXOGASTRIA;

EID: 0012290942     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01115.x     Document Type: Article

References (26)

1. 1. Cunliffe, W., Berth-Jones, J., Claudy, A., Fairiss, G., Goldin, D., Gratton, D., Henderson, C., Holden, C., Maddin, S., Ortonne, J.P. & Young, M. (1992) Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J. Am. Acad. Dermatol. 26, 736-743.
2. 2. Dübertret, L., Walbach, D., Souteyrand, P., Perussel, M., Kalis, B., Meynadien, J., Chevrant-Breton, J., Beylot, C., Bazex, J. & Jurgensen, H.J. (1992) Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study. J. Am. Acad. Dermatol. 27, 983-988.
3. 3. Ellis, J.P., Griffiths, W.A.D. & Klaber, M.R. (1995) Long-term treatment of chronic plaque psoriasis with calcipotriol ointment in patients unresponsive to short-contact dithranol. Eur. J. Clin. Res. 7, 247-257.
4. 4. Kragballe, K., Steijlen, P., Ibsen, H.H., van de Kerkhof, P.C.M., Esmann, J., Sorensen, L.H. & Axelsen, M.B. (1995) Efficacy, tolerability and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind vehicle-controlled, right/left comparative study. Arch. Dermatol. 131, 556-560.
5. 5. Kienbaum, S., Lehmann, P. & Ruzicka, T. (1996) Topical calcipotriol in the treatment of intertriginous psoriasis. Br. J. Dermatol. 135, 647-650.
6. 6. Darley, C.r., Cunliffe, W.J., Green, C.M., Hutchinson, P.E., Klaber, M.R. & Downes, N. (1996) Safety and efficacy of calcipotriol ointment (Dovonex®) in treating children with psoriasis vulgaris. Br. J. Dermatol. 135, 390-393.
7. 7. Reichrath, J., Müller, S.M., Kerber, A., Baum, H.P. & Bahmer, F. (1997) Biologic effects of topical calcipotriol (MC 903) treating in psoriatic skin. J. Am. Acad. Dermatol. 36, 19-28.
8. 3 [22-oxa] in vivo receptor binding in adult and developing skin. Arch. Dermatol. Res. 287, 294-303.
9. 3 receptors (VDR) in human skin. A comparison of five antibodies. Path. Res. Pract. 192, 281-289.
10. 3 analogues in transfected cultures of human keratinocytes. Skin Pharmacol. 10, 12-20.
11. 3 analogue calcipotriol suppresses the number and antigen-presenting functions of Langerhans cells in normal human skin. J. Invest. Dermatol. Symp. Proc. 1, 2-77.
12. 12. Yu, X.-P., Mocharla, H., Hustmyer, F.G. & Manolagas, S.C. (1991) Vitamin D receptor expression in human lymphocytes. J. Biol. Chem. 266, 7588-7595.
13. 13. Evans, R.M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240, 889-895.
14. 3 in cultured human keratinocytes. Arch. Dermatol. Res. 289, 367-372.
15. 15. Frank, N.R. & Pace, N.R. (1998) Ribonuclease P: unity and diversity in a tRNA processing ribozyme. Annu. Rev. Biochem. 67, 153-180.
16. 16. Guerrier-Takada, C., Gardiner, T., Marsh, K., Pace, N. & Altman, S. (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857.
17. 17. Symons, R.H. (1994) Ribozymes. Curr. Opin. Struct. Biol. 4, 322-330.
18. 18. Stathopoulos, C., Kalpaxis, D.L. & Drainas, D. (1995) Partial purification and characterization of RNase P from Dictyostelium discoideum. Eur. J. Biochem. 228, 976-980.
19. 19. Drainas, D. (1996) The RNase P of D. discoideum. Mol. Biol. Reports 22, 35-138.
20. 20. Papadimou, E., Georgiou, S., Tsambaos, D. & Drainas, D. (1998) Inhibition of ribonuclease P activity by retinoids. J. Biol. Chem. 38, 24375-24378.
21. 21. Drainas, D., Zimmerly, S., Willis, I. & Söll, D. (1989) Substrate structural requirements of Schizosaccharomyces pomhe RNase P. FEBS Lett. 251, 84-88,.
22. 22. de Boland, A.R. & Nemere, I. (1992) Rapid actions of vitamin D compounds. J. Cell Biochem. 49, 32-26.
23. 23. Bikle, D.D. & Pillai, S. (1993) Vitamin D, calcium and epidermal differentiation. Endocrine Rev. 14, 3-19.
24. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem. Pharmacol. 42, 1596-1575.
25. 25. Binderup, L., Carlberg, C., Kissmeyer, A., Lantini, S., Mathiasen, I.S. & Hansen, C.M. (1994) The need for new vitamin D analogues: mechanisms of action and clinical application. In: Vitamin D (Norman, A.W., Bouillon, R. & Thomasset, M., eds), pp. 55-63. de Gruyter, New York.
26. 3: a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. Steroid Biochem. Mol. Biol. 41, 231-240.